BEAM · Forms 3, 4, 5
Insider trades at Beam Therapeutics Inc.
2 insiders sold $1.2M of Beam Therapeutics Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Beam Therapeutics Inc. (BEAM) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| John M. Evans | CEO | Option exercise | 25,000 | $1.03 | $26K | Form 4 | |
| John M. Evans | CEO | Sell (10b5-1 plan) | 25,000 | $23.98 | $600K | Form 4 | |
| John M. Evans | CEO | Option exercise | 25,000 | $1.03 | $26K | Form 4 | |
| John M. Evans | CEO | Sell (10b5-1 plan) | 25,000 | $23.57 | $589K | Form 4 | |
| Bethany J Cavanagh | SVP, Finance and Treasurer | Sell (10b5-1 plan) | 187 | $24.41 | $5K | Form 4 | |
| Giuseppe Ciaramella | President | Gift | 123,407 | Form 4 | |||
| Amy Simon | Chief Medical Officer | Sell (10b5-1 plan) | 16,667 | $25.74 | $429K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.